Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Thank you for selecting your broker
We are redirecting you to the Broker Center now
Welcome to Please help us personalize your experience.

Select the one that best describes you
Thank you for your submission, we hope you enjoy your experience

NEW ETF Screener Launched! Filter and find profitable ETFs, quickly.

Etfdb logo
  • ETF
  • IHI
    Pricing Data
    Change: $0.83 (-0.01%)
    Time: 10/21/16
    Previous Close: $142.28
  • Category
  • Health & Biotech Equities
Last Updated:



Trading Data

Open: - Volume -
Day Lo - Day Hi -
  • 52 Week Lo: $106.94
  • 52 Week Hi: $146.91
  • AUM: $1,436.7 M
  • Shares: 10.1 M

Investment Themes

Historical Trading Data

  • 1 Month Avg. Volume: 102,513
  • 3 Month Avg. Volume: 122,562

Alternative ETFs in the Health & Biotech Equities Category

Sign Up for Pro to Unlock Data Sign Up
Type Ticker Expense Ratio Assets Avg. Daily Vol YTD Return
Largest (AUM)
Most Liquid (Volume)
Top YTD Performer

Analyst Report

This ETF focuses in on an interesting and often forgotten segment of the health care industry, the medical device makers. Companies in this segment tend to have more stable revenue streams, less issues with patent pipelines, and are often much smaller than their counterparts in big pharma. As a result of their size, many of the companies in IHI are found in very small quantities in large diversified health care ETFs such as XLV making IHI an interesting play to 'complete' exposure to the industry. However, while the industry may not have the same patent issues as pharma or the volatility of the biotech industry, it does have incredibly high levels of competition. This is because any commodity type products are easy to replicate while any patented products are often not crucial to a hospital and instead just make life a lot easier or more efficient for medical personnel, making these goods more 'luxury' in nature. Overall, IHI offers a nice mix of exposure in the industry and could be an excellent choice for investors who already are heavy in holdings to the pharma or broad health care industry but are still looking to round out overall exposure.

Realtime Rating

Sign Up for Pro to Unlock Data Sign Up

Realtime Rating Summary

The adjacent table gives investors an individual Realtime Rating for IHI on several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the Health & Biotech Equities with the highest Metric Realtime Rating for each individual field. To view all of this data, sign up for a free 14-day trial for ETFdb Pro. To view information on how the ETFdb Realtime Ratings work, click here.

Compare to another ETF

View the Category Report

IHI Overall Realtime Rating:

A+ Overall Rated ETF:

Metric Metric Realtime Rating A+ Metric Rated ETF
Liquidity B+ n/a
Expenses B+ n/a

Knowledge Centers

IHI In-Depth Analysis

The following tables and charts contain in-depth metrics for this ETF and compare it to similar peer ETFs within its ETFdb Category.

IHI Holdings

Filings Data as of: Oct 04, 2016
Sign Up for Pro to Unlock Data Sign Up

Concentration Analysis

This section compares how balanced and deep this ETF is relative to the peer group ETFdb Category.

Number of Holdings
Category Low
Category High
% Assets in Top 10
Category Low
Category High

Asset Allocation

Asset Percentage
U.S. Stocks 99.81%
International Stocks 0.0%
U.S. Bonds 0.0%
International Bonds 0.0%
Preferred Stock 0.0%
Convertibles 0.0%
Cash 0.19%
Other 0.0%

Sector Breakdown

Sector Percentage
Health Care 93.08%
Industrials 6.3%
Technology 0.42%
Financial Services 0.0%
Real Estate 0.0%
Consumer Defensive 0.0%
Consumer Cyclical 0.0%
Basic Materials 0.0%
Energy 0.0%
Communication Services 0.0%
Utilities 0.0%

Market Cap Breakdown

Market Cap Percentage
Giant 12.72%
Large 56.7%
Medium 20.07%
Small 7.74%
Micro 2.58%

Region Breakdown

Region Percentage
U.S. 99.81%
Middle East 0.0%
Australia 0.0%
Japan 0.0%
Asia (Developed) 0.0%
Africa 0.0%
Europe 0.0%
Latin America 0.0%
Canada 0.0%
Asia (Emerging) 0.0%

Market Tier Breakdown

Region Percentage
Developed 99.81%
Emerging 0.0%

Country Breakdown

Country Percentage
United States 99.81%
Other 0.19%

IHI Expenses & Fees

This section compares the cost efficiency of this ETF to peers in the same ETFdb Category.

Sign Up for Pro to Unlock Data Sign Up

Expenses Ratio Analysis

ETF Average
ETF Wtd. Average
Category Average
Expense Ratio
Category Low
Category High

Commission Free Trading

This ETF is not currently available for commission free trading on any platforms.

Category Commission Free Trading

There are 3 other ETFs in the Health & Biotech Equities ETFdb Category that are also eligible for commission free trading:

IHI Performance

This section shows how this ETF has performed relative to its peer group ETFdb Category.

1 Week Return
Category Low
Category High
4 Week Return
Category Low
Category High
13 Week Return
Category Low
Category High
26 Week Return
Category Low
Category High
Year to Date Return
Category Low
Category High
1 Year Return
Category Low
Category High
3 Year Return
Category Low
Category High
5 Year Return
Category Low
Category High

Brought to You by Mitre Media


The following charts can be customized to display historical performance in a number of different formats, including line charts, bar charts, and candlesticks. Time periods can be adjusted to increase or decrease the period shown, ranging from five minutes to several months.

The following chart also includes the option to compare the performance of IHI relative to other ETFs and benchmarks or to include indicators such as Bollinger Bands, relative strength, and moving averages.

IHI Valuation

This section shows how the P/E multiple of this ETF compares to the peer group ETFdb Category.

Sign Up for Pro to Unlock Data Sign Up
P/E Ratio
Category Low
Category High

As of Aug 25 2016

IHI Dividend

This section shows how the dividend yield of this ETF compares to the peer group ETFdb Category.

Sign Up for Pro to Unlock Data Sign Up
Dividend Date
Annual Dividend Rate
Annual Dividend Yield
Category Low
Category High

As of Aug 25, 2016

IHI Technicals

Sign Up for Pro to Unlock Data Sign Up

Volatility Analysis

This section shows how the volatility of this ETF compares to the peer group ETFdb Category.

5 Day Volatility
Category Low
Category High
20 Day Volatility
Category Low
Category High
50 Day Volatility
Category Low
Category High
200 Day Volatility
Category Low
Category High
Category Low
Category High
Standard Deviation
Category Low
Category High


  • 20 Day MA: $143.44
  • 60 Day MA: $143.54
  • MACD 15 Period: -1.55
  • MACD 100 Period: 0.89
  • Williams % Range 10 Day: 85.98
  • Williams % Range 20 Day: 85.98
  • RSI 10 Day: 43
  • RSI 20 Day: 46
  • RSI 30 Day: 49
  • Ultimate Oscillator: 49

Bollinger Brands

  • Lower Bollinger (10 Day): $139.21
  • Upper Bollinger (10 Day): $145.16
  • Lower Bollinger (20 Day): $140.11
  • Upper Bollinger (20 Day): $146.80
  • Lower Bollinger (30 Day): $139.51
  • Upper Bollinger (30 Day): $146.84

Support & Resistance

  • Support Level 1: $140.95
  • Support Level 2: $140.45
  • Resistance Level 1: $141.76
  • Resistance Level 2: $142.07


  • Stochastic Oscillator %D (1 Day): 60.18
  • Stochastic Oscillator %D (5 Day): 50.02
  • Stochastic Oscillator %K (1 Day): 47.95
  • Stochastic Oscillator %K (5 Day): 44.42

Fact Sheet

Fact sheets are issued by the ETF provider and framed by Information contained within the fact sheet is not guaranteed to be timely or accurate.

2014 Morningstar, Inc. All Rights Reserved. The information contained herein: ( 1 ) is proprietary to Morningstar and/or its content providers; ( 2 ) may not be copied or distributed; and ( 3 ) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.